| Application no. and date | 16747066.5 (espacenet) (Federated) (European Patent Register), 20160201 | | Patent/reg. no. and date | DK/EP 3253208, 20210505 | | Publication date | 20171213 | | Priority no. and date | US 201562111030 P, 20150202 | | EP pub. no. and date |
EP 3253208 20171213 | | Effective date | | | Applicant/owner | The Spanish National Cancer Research Centre, Melchor Fernandez Almagro 3
28029 Madrid, ES,
MEI Pharma, Inc., 11455 El Camino Real, Suite 250
San Diego, CA 92130, US | | Applicant ref. no. | V342699DK00 | | Inventor | QUINTELA-FANDINO, Miguel, Melchor Fernandez Almagro 3
28029 Madrid, ES,
GOLD, Daniel P., 11455 El Camino Real
Suite 250
San Diego
CA 92130, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A01N 43/42 (2006.01) , A61K 31/353 (2006.01) , A61K 31/44 (2006.01) , A61K 31/496 (2006.01) , A61K 45/06 (2006.01) , A61P 35/00 (2006.01) | | Title | Kombinationsterapier til anvendelse i behandlingen af brystcancer | | Int. application no. | US2016016008 | | Int. publication no. | WO2016126618 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
